Oramed Pharmaceuticals Inc. ( ORMP) - Key Metrics

ORMP Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $0 $1.90 $0 $0
2026Q1 $0 $0.94 -$0.07 -$0.07
2025Q4 $0 $0.24 -$0.01 -$0.01
2025Q3 $0 $1.16 -$0.05 -$0.05
2025Q2 $0 $0.32 -$0.09 -$0.09

ORMP Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0.10% 0.63
2026Q1 26.61% 0.90
2025Q4 0% 3.10
2025Q3 0% 0.57
2025Q2 0% 1.76

ORMP Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 -0.10% 0.04%
2026Q1 -2.11% 7.35%
2025Q4 -0.22% 0%
2025Q3 -1.80% 0%
2025Q2 -3.80% 0%

ORMP

Price: $4.68

52 week price:
1.91
5.19

Payout Ratio Range:
0.10%
26.61%

Earnings Per Share: 4.13 USD

P/E Ratio: 1.08

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.6 million

Ebitda: -2.5 million

Market Capitalization: 186.4 million

Years Paying Dividends: 1

Links: